ru uk en-us pl fr de nl da ca bg af ar eu sq be bs hy az bn ceb ny

Category Help  

Fenikaberan Instructions Description of the drug


2016-12-28 00:00:00

Name: Fenikaberan Phenicaberanum

Pharmacological action:
Antispasmodic agent relieves spasms.


Indications:
Apply with chronic coronary insufficiency mismatch between the need of the heart for oxygen and its delivery with angina; in diseases of the digestive tract, accompanied by spasms of smooth muscle organs, chronic cholecystitis inflammation of the gallbladder.


Dosing:
Inside regardless of the meal administered to 0.02 g 3-6 times a day, intramuscularly -2 ml of a 0.25% solution of 0.005 g of 2-3 times a day. Duration of treatment -4-6 weeks.
Drug is more effective when administered parenterally administered intramuscularly than when taken orally.
For relief relieve angina attacks fenikaberan administered only intramuscularly with 2 ml of 0.25% solution.


Side effects:
Dizziness, headache, weakness, poor appetite; in these cases, reduce the dose or temporarily stop taking the drug.


Contraindications:
Chronic nephritis nephritis with edema and impaired renal function azotvydelitelnoy, bleeding peptic ulcer, diabetes, and pregnancy. Caution is needed in case of myocardial infarction in the acute period. When high blood pressure drug overturned.


Product:
Coated tablets, 0.02 grams in a package of 20 pieces; 0.25% solution in 2 ml ampoules in a package of 10 pieces.


Storage conditions:
List B. In the dark spot.


Attention!
Before using the medication Fenikaberan , you should consult your doctor. This operating instruction is given a free transfer and is intended solely for information. For more information, please contact the manufacturer annotations.




Related articles

 Deytiforin Instructions Description of the drug
 Morshinskaya s alt laxative drug Instruction Description
 Kolfostseril palminat drug Instruction Description
 Lyutenurin Instructions Description of the drug
 

Site is a private collection of materials and is an amateur informational and educational resource. All information is obtained from public sources. The administration does not apply for authorship of the materials used. All rights belong to their owners